tradingkey.logo

Transcat Inc

TRNS
View Detailed Chart

75.740USD

+3.130+4.31%
Close 09/18, 16:00ETQuotes delayed by 15 min
705.78MMarket Cap
52.80P/E TTM

Transcat Inc

75.740

+3.130+4.31%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.31%

5 Days

-0.88%

1 Month

-7.90%

6 Months

+6.27%

Year to Date

-28.37%

1 Year

-41.01%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-18

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
24 / 60
Overall Ranking
147 / 4721
Industry
Electronic Equipment & Parts

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
109.400
Target Price
+50.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. It is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its segments include Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Its Distribution segment sells and rents national and proprietary brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 26 calibration service centers located across the United States, Puerto Rico, Canada, and Ireland.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.75% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 35.81.
Undervalued
The company’s latest PB is 2.41, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 9.77M shares, increasing 0.37% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 526.72K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. It is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its segments include Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Its Distribution segment sells and rents national and proprietary brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 26 calibration service centers located across the United States, Puerto Rico, Canada, and Ireland.
Ticker SymbolTRNS
CompanyTranscat Inc
CEOMr. Lee D. Rudow
Websitehttps://www.transcat.com/
KeyAI